ALXN
1832 Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-114,000
| Closed | -$12.9M | – | 764 |
|
|
2020
Q3 | $12.9M | Hold |
114,000
| – | – | 0.03% | 240 |
|
|
2020
Q2 | $12.8M | Sell |
114,000
-224,609
| -66% | -$25.2M | 0.04% | 223 |
|
|
2020
Q1 | $29.8M | Buy |
+338,609
| New | +$29.8M | 0.11% | 143 |
|
|
2019
Q3 | – | Sell |
-898,200
| Closed | -$112M | – | 783 |
|
|
2019
Q2 | $112M | Buy |
898,200
+850,200
| +1,771% | +$106M | 0.36% | 71 |
|
|
2019
Q1 | $6.43M | Buy |
+48,000
| New | +$6.43M | 0.02% | 257 |
|
|
2017
Q4 | – | Sell |
-1,320
| Closed | -$180K | – | 755 |
|
|
2017
Q3 | $180K | Buy |
+1,320
| New | +$180K | ﹤0.01% | 531 |
|
|
2016
Q1 | – | Sell |
-250,000
| Closed | -$46.3M | – | 713 |
|
|
2015
Q4 | $46.3M | Buy |
+250,000
| New | +$46.3M | 0.2% | 118 |
|
|
2015
Q1 | – | Sell |
-666,000
| Closed | -$122M | – | 701 |
|
|
2014
Q4 | $122M | Buy |
666,000
+91,300
| +16% | +$16.7M | 0.38% | 72 |
|
|
2014
Q3 | $94.6M | Buy |
574,700
+131,900
| +30% | +$21.7M | 0.31% | 88 |
|
|
2014
Q2 | $68.9M | Sell |
442,800
-128,900
| -23% | -$20.1M | 0.22% | 120 |
|
|
2014
Q1 | $84.3M | Buy |
571,700
+45,500
| +9% | +$6.71M | 0.29% | 91 |
|
|
2013
Q4 | $69.5M | Sell |
526,200
-80,700
| -13% | -$10.7M | 0.27% | 95 |
|
|
2013
Q3 | $70M | Buy |
+606,900
| New | +$70M | 0.31% | 89 |
|